Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial to evaluate the efficacy and safety of Duvakitug in participants with moderately to severely active ulcerative colitis is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duvakitug

Snippet

Sponsor: Sanofi | Conditions: Ulcerative Colitis | Phase 3 | Status: RECRUITING